Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Statistics

Total Valuation

LEXX has a market cap or net worth of $20.95 million. The enterprise value is $14.62 million.

Market Cap	20.95M
Enterprise Value	14.62M

Important Dates

The next estimated earnings date is Friday, July 11, 2025.

Earnings Date	Jul 11, 2025
Ex-Dividend Date	n/a

Share Statistics

LEXX has 19.48 million shares outstanding. The number of shares has increased by 84.74% in one year.

Current Share Class	19.48M
Shares Outstanding	19.48M
Shares Change (YoY)	+84.74%
Shares Change (QoQ)	+5.06%
Owned by Insiders (%)	7.98%
Owned by Institutions (%)	7.43%
Float	17.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	32.72
Forward PS	43.52
PB Ratio	2.65
P/TBV Ratio	3.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	27.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.02.

Current Ratio	4.24
Quick Ratio	3.77
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -145.55% and return on invested capital (ROIC) is -88.48%.

Return on Equity (ROE)	-145.55%
Return on Assets (ROA)	-77.60%
Return on Invested Capital (ROIC)	-88.48%
Return on Capital Employed (ROCE)	-136.10%
Revenue Per Employee	$75,132
Profits Per Employee	-$1.34M
Employee Count	7
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.72% in the last 52 weeks. The beta is 1.00, so LEXX's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-69.72%
50-Day Moving Average	1.41
200-Day Moving Average	2.27
Relative Strength Index (RSI)	36.24
Average Volume (20 Days)	111,269

Short Selling Information

The latest short interest is 588,078, so 3.02% of the outstanding shares have been sold short.

Short Interest	588,078
Short Previous Month	520,182
Short % of Shares Out	3.02%
Short % of Float	3.34%
Short Ratio (days to cover)	5.08

Income Statement

In the last 12 months, LEXX had revenue of $525,923 and -$9.38 million in losses. Loss per share was -$0.59.

Revenue	525,923
Gross Profit	523,203
Operating Income	-9.33M
Pretax Income	-4.83M
Net Income	-9.38M
EBITDA	-9.26M
EBIT	-9.33M
Loss Per Share	-$0.59

Balance Sheet

The company has $6.54 million in cash and $123,723 in debt, giving a net cash position of $6.42 million or $0.33 per share.

Cash & Cash Equivalents	6.54M
Total Debt	123,723
Net Cash	6.42M
Net Cash Per Share	$0.33
Equity (Book Value)	6.76M
Book Value Per Share	0.41
Working Capital	5.90M

Cash Flow

In the last 12 months, operating cash flow was -$7.38 million and capital expenditures -$67,660, giving a free cash flow of -$7.45 million.

Operating Cash Flow	-7.38M
Capital Expenditures	-67,660
Free Cash Flow	-7.45M
FCF Per Share	-$0.38

Margins

Gross Margin	99.48%
Operating Margin	-1,774.00%
Pretax Margin	-1,786.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LEXX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.74%
Shareholder Yield	-84.74%
Earnings Yield	-44.59%
FCF Yield	-35.40%

Analyst Forecast

The average price target for LEXX is $7.00, which is 551.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	551.16%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	173.91%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 12, 2021. It was a reverse split with a ratio of 0.0333333:1.

Last Split Date	Jan 12, 2021
Split Type	Reverse
Split Ratio	0.0333333:1

Scores

LEXX has an Altman Z-Score of 1.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.28
Piotroski F-Score	2